Denmark
· Delayed Price · Currency is DKK ViroGates Statistics
Total Valuation
ViroGates has a market cap or net worth of DKK 38.03 million. The enterprise value is 34.59 million.
| Market Cap | 38.03M |
| Enterprise Value | 34.59M |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ViroGates has 6.44 million shares outstanding. The number of shares has increased by 92.51% in one year.
| Shares Outstanding | 6.44M |
| Shares Change (YoY) | +92.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 52.67% |
| Owned by Institutions (%) | n/a |
| Float | 2.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.51 |
| PB Ratio | 4.08 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.63 |
| EV / Sales | 5.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.70 |
Financial Position
The company has a current ratio of 11.74, with a Debt / Equity ratio of 0.57.
| Current Ratio | 11.74 |
| Quick Ratio | 8.48 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.41 |
| Interest Coverage | -18.36 |
Financial Efficiency
Return on equity (ROE) is -140.07% and return on invested capital (ROIC) is -56.78%.
| Return on Equity (ROE) | -140.07% |
| Return on Assets (ROA) | -52.30% |
| Return on Capital (ROIC) | -56.78% |
| Revenue Per Employee | 690,300 |
| Profits Per Employee | -1.31M |
| Employee Count | 10 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 0.39 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.04% in the last 52 weeks. The beta is 0.94, so ViroGates's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -72.04% |
| 50-Day Moving Average | 5.92 |
| 200-Day Moving Average | 6.86 |
| Relative Strength Index (RSI) | 52.34 |
| Average Volume (20 Days) | 1,588 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ViroGates had revenue of DKK 6.90 million and -13.13 million in losses. Loss per share was -2.04.
| Revenue | 6.90M |
| Gross Profit | 5.28M |
| Operating Income | -13.33M |
| Pretax Income | -14.02M |
| Net Income | -13.13M |
| EBITDA | -13.30M |
| EBIT | -13.33M |
| Loss Per Share | -2.04 |
Balance Sheet
The company has 8.74 million in cash and 5.30 million in debt, giving a net cash position of 3.44 million or 0.53 per share.
| Cash & Cash Equivalents | 8.74M |
| Total Debt | 5.30M |
| Net Cash | 3.44M |
| Net Cash Per Share | 0.53 |
| Equity (Book Value) | 9.32M |
| Book Value Per Share | 1.45 |
| Working Capital | 14.44M |
Cash Flow
In the last 12 months, operating cash flow was -12.82 million and capital expenditures -1,000, giving a free cash flow of -12.83 million.
| Operating Cash Flow | -12.82M |
| Capital Expenditures | -1,000 |
| Free Cash Flow | -12.83M |
| FCF Per Share | -1.99 |
Margins
Gross margin is 76.53%, with operating and profit margins of -193.13% and -190.25%.
| Gross Margin | 76.53% |
| Operating Margin | -193.13% |
| Pretax Margin | -203.13% |
| Profit Margin | -190.25% |
| EBITDA Margin | -192.64% |
| EBIT Margin | -193.13% |
| FCF Margin | -185.79% |
Dividends & Yields
ViroGates does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -92.51% |
| Shareholder Yield | -92.51% |
| Earnings Yield | -34.54% |
| FCF Yield | -33.73% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ViroGates has an Altman Z-Score of 3.64.
| Altman Z-Score | 3.64 |
| Piotroski F-Score | n/a |